|
1
|
Lin F, Yang Y, Guo Q, Xie M, Sun S, Wang
X, Li D, Zhang G, Li M, Wang J and Zhao G: Analysis of the
molecular mechanism of acute coronary syndrome based on
circRNA-miRNA network regulation. Evid Based Complement Alternat
Med. 2020(1584052)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chandiramani R, Cao D and Mehran R:
Periprocedural anticoagulation in non-ST-segment elevation acute
coronary syndrome: Time to reassess? Ann Transl Med.
8(556)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Huang ZS, Zheng ZD, Zhang JW, Tang LL,
Zhou LL, Li SH, Xie XJ, Dong RM, Zhu JM and Liu JL: Association of
major adverse cardiovascular events and cardiac troponin-I levels
following percutaneous coronary intervention: A three-year
follow-up study at a single center. Eur Rev Med Pharmacol Sci.
24:3981–3992. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ming F and Sun Q: Epigenetically silenced
PTPRO functions as a prognostic marker and tumor suppressor in
human lung squamous cell carcinoma. Mol Med Rep. 16:746–754.
2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dong H, Ma L, Gan J, Lin W, Chen C, Yao Z,
Du L, Zheng L, Ke C, Huang X, et al: PTPRO represses ERBB2-driven
breast oncogenesis by dephosphorylation and endosomal
internalization of ERBB2. Oncogene. 36:410–422. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yan S, Cheng M, Duan Q, Wang Z, Gao W, Ren
B and Xu D: MiR-6803-5p promotes cancer cell proliferation and
invasion via PTPRO/NF-κB axis in colorectal cancer. Mediators
Inflamm. 2019(8128501)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xu D, Wang X, Yan S, Yin Y, Hou J, Wang X
and Sun B: Interaction of PTPRO and TLR4 signaling in
hepatocellular carcinoma. Tumour Biol. 35:10267–10273.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Qi C, Shao Y, Liu X, Wang D and Li X: The
cardioprotective effects of icariin on the isoprenaline-induced
takotsubo-like rat model: Involvement of reactive oxygen species
and the TLR4/NF-κB signaling pathway. Int Immunopharmacol.
74(105733)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tang YL, Jiang JH, Wang S, Liu Z, Tang XQ,
Peng J, Yang YZ and Gu HF: TLR4/NF-κB signaling contributes to
chronic unpredictable mild stress-induced atherosclerosis in
ApoE-/- mice. PLoS One. 10(e0123685)2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao J, Yan S, Zhu X, Bai W, Li J and
Liang C: PTPRO exaggerates inflammation in ulcerative colitis
through TLR4/NF-κB pathway. J Cell Biochem. 121:1061–1071.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liang C, Wang X, Hu J, Lian X, Zhu T,
Zhang H, Gu N and Li J: PTPRO promotes oxidized low-density
lipoprotein induced oxidative stress and cell apoptosis through
toll-like receptor 4/nuclear factor κB pathway. Cell Physiol
Biochem. 42:495–505. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chinese Medical Association Emergency
Physicians Branch, Chinese Medical Association Cardiovascular
Medicine Branch and Chinese Medical Association Laboratory Medicine
Branch. Guidelines for the rapid diagnosis and treatment of acute
coronary syndrome in the emergency department. Chin J Emerg Med.
25:397–404. 2016.
|
|
13
|
Zhao JW, Shi G, Ping JD and Ming L: Study
on the negative regulation of TIPE2 from peripheral blood
mononuclear cells on tissue factor in patients with bronchial
asthma. Zhonghua Yi Xue Za Zhi. 98:2889–2893. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
14
|
Ye G, Qin Y, Wang S, Pan D, Xu S, Wu C,
Wang X, Wang J, Ye H and Shen H: Lamc1 promotes the Warburg effect
in hepatocellular carcinoma cells by regulating PKM2 expression
through AKT pathway. Cancer Biol Ther. 20:711–719. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gowdak LHW: Atherosclerosis, inflammation,
and genetics- and you thought it was just LDL-cholesterol. Arq Bras
Cardiol. 114:273–274. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Frodermann V, Rohde D, Courties G, Severe
N, Schloss MJ, Amatullah H, McAlpine CS, Cremer S, Hoyer FF, Ji F,
et al: Exercise reduces inflammatory cell production and
cardiovascular inflammation via instruction of hematopoietic
progenitor cells. Nat Med. 25:1761–1771. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang Y, Zhang C and Zhang M: A new era of
anti-inflammatory therapy for atherosclerosis. Zhonghua Xin Xue
Guan Bing Za Zhi. 46:332–337. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
18
|
Sun YF and Guo DL: Research progress of
the relationship between inflammatory factor and coronary heart
disease. China Mod Med. 24:12–15. 2017.
|
|
19
|
Szekely Y and Arbel Y: A review of
interleukin-1 in heart disease: Where do we stand today? Cardiol
Ther. 7:25–44. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gao S, Shu S, Wang L, Zhou J and Yuan Z:
Pro-inflammatory and anti-inflammatory cytokine responses of
peripheral blood mononuclear cells in apparently healthy subjects.
Nan Fang Yi Ke Da Xue Xue Bao. 34:1589–1593. 2014.PubMed/NCBI(In Chinese).
|
|
21
|
Ridker PM, Everett BM, Thuren T, MacFadyen
JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker
SD, et al: Antiinflammatory therapy with canakinumab for
atherosclerotic disease. N Engl J Med. 377:1119–1131.
2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Dongxu H, Yundi J, Jia S, Zongyu W, Jiake
W, Weili D, Na S, Tongtong Y, Zhijun S and Zaoqing S: The effects
of C-reactive protein and albumin ratio on the prognoses in
patients with acute coronary syndrome. Chin J Cardiovasc Res.
16:1090–1094. 2018.
|
|
23
|
Hou J, Xia Y, Jiang R, Chen D, Xu J, Deng
L, Huang X, Wang X and Sun B: PTPRO plays a dual role in hepatic
ischemia reperfusion injury through feedback activation of NF-κB. J
Hepatol. 60:306–312. 2014.PubMed/NCBI View Article : Google Scholar
|
